• Aloin Isoforms as Selective Inhibitors of SARS-CoV-2 PLpro A

  2026-08-04

  The reference study demonstrates that aloin A and B, natural isoforms found in oral rinse products, selectively inhibit the proteolytic and deubiquitinating activity of SARS-CoV-2 papain-like protease (PLpro) in vitro. These findings illuminate a specific antiviral mechanism of oral rinse components and highlight the importance of targeted enzymatic inhibition in antiviral research.

• Strategic Insights: Pertussis Toxin in Translational Immune

  2026-08-04

  This thought-leadership article explores how Pertussis toxin, a classic AB5-type protein exotoxin, is transforming translational immunology. Blending mechanistic insight with strategic experimental guidance, we uncover how this versatile tool is redefining immune response modulation, from TH17 cell biology to precision vaccine development. Drawing on recent advances in chromatin accessibility, cAMP signaling, and dendritic cell research, we offer actionable recommendations for optimizing protocols and catalyzing impactful discoveries, while highlighting APExBIO’s high-purity Pertussis toxin.

• Engineered Klotho mRNA Delivery Reverses Senescence in iMSCs

  2026-08-03

  This study introduces a hyperbranched poly(β-amino ester) (HPAE)-mediated system for delivering engineered Klotho mRNA, successfully reversing senescence and restoring mitochondrial function in aged and Klotho-deficient induced mesenchymal stem cells (iMSCs). The findings highlight the translational promise of mRNA-based therapeutics in regenerative medicine and cellular aging intervention.

• Ajugol Modulates PI3K/AKT/mTOR to Suppress Gouty Arthritis P

  2026-08-03

  This study identifies ajugol as a potent modulator of the PI3K/AKT/mTOR pathway, attenuating acute gouty arthritis by enhancing mitophagy and suppressing chondrocyte pyroptosis. The findings provide mechanistic clarity and a foundation for developing mitochondrial-targeted therapies in inflammatory joint diseases.

• Solanesol Protocol Guidance for Polyisoprenoid Alcohol Resea

  2026-08-02

  Solanesol is a high-purity polyisoprenoid alcohol designed for research applications that require precise handling of hydrophobic compounds. It is intended for workflows such as apoptosis research, DNA damage and repair studies, and metabolic enzyme assays, but is unsuitable for aqueous or ethanol-based systems and is not for diagnostic or medical use.

• Cytokine and Glucocorticoid Regulation of BIRC2/3 in Lung Ep

  2026-08-01

  This study reveals distinct regulatory mechanisms for BIRC2 and BIRC3 expression in human pulmonary epithelial cells exposed to inflammatory cytokines and glucocorticoids. The findings clarify differential roles for these IAP family members in cell signaling and apoptosis, with implications for lung barrier defense and inflammation research.

• Mubritinib–HSA Interactions: Implications for Drug Bioavaila

  2026-07-31

  This study deciphers the molecular basis of mubritinib binding to human serum albumin (HSA), revealing moderate affinity and functional disruption of the carrier protein. These findings clarify critical pharmacokinetic parameters of electron transport chain inhibitors in cancer research and support rational drug design.

• Translational Precision: EZ Cap™ Firefly Luciferase mRNA (5-

  2026-07-31

  Explore how Firefly Luciferase mRNA with 5-moUTP modifications redefines mRNA delivery and translation efficiency assays. This article unveils practical advances in lipid nanoparticle manufacturing and assay design, setting a new benchmark for bioluminescent reporter applications.

• Redefining Cell Viability Measurement in Translational Oncol

  2026-07-30

  This article provides translational researchers with a mechanistic lens into advanced luciferase-based cell viability assays, highlighting how the APExBIO Luminescent ATP Cell Viability Assay Kit I empowers precise interrogation of antiproliferative strategies, such as peptide-based tumor suppressor delivery in glioblastoma. Integrating recent findings and comparative literature, it delivers both mechanistic insight and actionable guidance for future-forward translational workflows.

• Clarithromycin as a CYP3A Inhibitor: Applied Research Workfl

  2026-07-30

  Harness the precision of Clarithromycin for CYP3A inhibition in drug-drug interaction and pharmacokinetic research. This guide delivers actionable protocols, troubleshooting strategies, and comparative insights that empower studies of statin and cardiovascular drug metabolism.

• CD40–STING–TRAF2 Axis Drives B Cell Activation in ESCC TLS

  2026-07-29

  This study elucidates how competitive binding of CD40 and STING with TRAF2 modulates IRF4-mediated B cell activation within tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma (ESCC). The findings clarify essential mechanisms in TLS biology and highlight new directions for biomarker discovery and immune-based interventions.

• Geneticin (G-418 Sulfate): Next-Gen Selection and Antiviral

  2026-07-29

  This thought-leadership article explores Geneticin (G-418 Sulfate) as a pivotal reagent at the intersection of genetic engineering and antiviral research, integrating mechanistic depth with actionable guidance for translational scientists. We examine the ribosomal inhibition pathway, validation in cell selection and Dengue virus research, competitive positioning, and future horizons—anchored by the latest evidence and best practices.

• BMS-345541 Hydrochloride: Reliable IKK Inhibitor for NF-κB R

  2026-07-28

  This scenario-driven guide explores how BMS-345541 hydrochloride (SKU A3248) addresses reproducibility, selectivity, and workflow challenges in NF-κB pathway research. Through evidence-backed Q&A, biomedical scientists gain actionable insights into assay optimization, apoptosis induction, and vendor selection, positioning SKU A3248 as a reliable solution for inflammation and cancer biology studies.

• 2-Hydroxypropyl-β-cyclodextrin: Technical Protocols and QC G

  2026-07-28

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of solubilizing poorly water-soluble, hydrophobic compounds—especially those with aromatic or phenyl groups—by forming inclusion complexes in aqueous environments. It is validated as a drug formulation excipient or for pharmaceutical solubility improvement; applications outside these workflows are not supported by current documentation.

• Nonivamide (Capsaicin Analog): Data-Driven TRPV1 Assay Optim

  2026-07-27

  This article dissects real laboratory challenges in TRPV1-mediated cancer and neuroinflammation research, demonstrating how Nonivamide (Capsaicin Analog, SKU A3278) delivers reproducible, literature-backed solutions. Scenario-based Q&A connects practical assay needs—like apoptosis quantification, anti-proliferative benchmarking, and workflow reliability—to validated use cases and protocol best practices for Nonivamide.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page